- Market Realist•2 days ago
The overall contribution of the innovative medicines segment was ~67% at $8,173 million for 3Q16.
- Market Realist•3 days ago
Novartis (NVS) reported a flat top line at a constant exchange rate for 3Q16 as compared to 3Q15 revenues.
- Forbes•3 days ago
Trump hasn’t yet entered the Oval Office, but he’s already showing an uncanny knack for creating quick stock dips with just a sentence or two.
NVS.BA : Summary for NOVARTIS AG CEDEAR EACH REP 0.5 - Yahoo Finance
NOVARTIS AG CEDEAR EACH REP 0.5 (NVS.BA)
Buenos Aires - Buenos Aires Delayed Price. Currency in ARS
Add to watchlist
|Day's Range||566.85 - 566.85|
|52 Week Range||566.85 - 585.00|
|PE Ratio (TTM)||N/A|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|